Cellular characteristics of head and neck cancer stem cells in type IV collagen-coated adherent cultures

Experimental Cell Research

Volumn 318, Issue 10, 2012, Pages 1104-1111

  Lim, Young Chang ^a   Oh, Se Yeong ^b   Kim, Hyunggee ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Korea University   (South Korea)

Author keywords

Adherent cultures; Cancer stem cell; Head neck cancer; Type IV collagen

Indexed keywords

CISPLATIN; COLLAGEN TYPE 4; DOCETAXEL; FIBRONECTIN; FLUOROURACIL; HERMES ANTIGEN; LAMININ; LENTIVIRUS VECTOR; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL CULTURE; CELL DEATH; CELL EXPANSION; CELL GROWTH; CONTROLLED STUDY; FEMALE; GENETIC TRANSDUCTION; GROWTH RATE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

MUS MUSCULUS;

EID: 84862813687     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.02.038     Document Type: Article

References (30)

1. Shackleton M., Quintana E., Fearon E.R., Morrison S.J. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009, 138:822-829.
2. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 2005, 5:275-284.
3. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
4. Mor G., Yin G., Ghefetz I., Yang Y., Alvero A. Ovarian cancer stem cells and inflammation. Cancer Biol Ther 2011, 11:708-713.
5. Kim C.F., Jackson E.L., Woolfenden A.E., Lawrence S., Babar I., Vogel S., Crowley D., Bronson R.T., Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005, 121:823-835.
6. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-10951.
7. Dalerba P., Dylla S.J., Park I.K., Liu R., Wang X., Cho R.W., Hoey T., Gurney A., Huang E.H., Simeone D.M., Shelton A.A., Parmiani G. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10158-10163.
8. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3983-3988.
9. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
10. Joshua B., Kaplan MJ., Doweck I., Pai R., Weissman IL., Prince ME., Ailles LE. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness. Head Neck 2012, 34:42-49.
11. Lim Y.C., Oh S.Y., Cha Y.I., Kim S.H., Jin X., Kim H. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncol. 2011, 47:83-91.
12. Reynolds B.A., Rietze R.L. Neural stem cells and neurospheres re-evaluating the relationship. Nat. Methods 2005, 2:333-336.
13. Pollard S.M., Yoshikawa K., Clarke I.D., Danovi D., Stricker S., Russell I.R., Bayani J., Head R., Lee M., Bernstein M., Squire J.A., Smith A. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009, 4:568-580.
14. Singec I., Knoth R., Meyer R.P., Maciaczyk J., Volk B., Nikkhah G., Frotscher M., Snyder E.Y. Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nat. Methods 2006, 3:801-806.
15. Grill J., Lamfers M.L., van Beusechem V.W., Dirven C.M., Pherai D.S., Kater M., Van der Valk P., Vogels R., Vandertop W.P., Pinedo H.M., Curiel D.T., Gerritsen W.R. The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro. Mol. Ther. 2002, 6:609-614.
16. Ziober A.F., Falls E.M., Ziober B.L. The extracellular matrix in oral squamous cell carcinoma: friend or foe?. Head Neck 2006, 28:740-749.
17. H.N. Suh, H.J. Han, Collagen I regulates the self-renewal of mouse embryonic stem cells through α2β1 integrin- and DDR1-dependent Bmi-1. J. Cell. Physiol. 226 (12) (2011) 3422-3432.
18. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
19. Zhang S., Balch C., Chan M.W., Lai H.C., Matei D., Schilder J.M., Yan P.S., Huang T.H., Nephew K.P. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008, 68:4311-4320.
20. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:973-978.
21. Lim Y.C., Oh S.Y., Cha Y.Y., Kim S.H., Kim H. Cancer stem cell traits in squamouspheres derived from primary head and neck squamous cell carcinomas. Oral Oncol. 2011, 47:83-91.
22. Dalerba P., Dylla S.J., Park I.K., Liu R., Wang X., Cho R.W., Hoey T., Gurney A., Huang E.H., Simeone D.M., Shelton A.A., Parmiani G., Castelli C., Clarke M.F. Phenotypic characterization of human colorectal cancer stem cell. Proc. Natl. Acad. Sci. U. S. A. 2007, 12:10158-10163.
23. Stenback F., Makinen M.J., Jussila T., Kauppila S., Ristell J., Talve L., Risteli L. The extracellular matrix in skin development: a morphological study. J. Cutan. Pathol. 1997, 26:327-338.
24. Krecicki T., Zalesska-Krecicka M., Jelen M., Szkudlarek T., Horobiowska M. Expression of type IV collagen and matrix metalloproteinase-2 (type IV collagenase) in relation to nodal status in laryngeal cancer. Clin. Otolaryngol. Allied Sci. 2001, 26:469-472.
25. Prowse A.B., Chong F., Gray P.P., Munro T.P. Stem cell integrins: implications for ex-vivo culture and cellular therapies. Stem Cell Res. 2011, 6:1-12.
26. Kirkland S.C., Ying H. Alpha2beta1 integrin regulates lineage commitment in multipotent human colorectal cancer cells. J. Biol. Chem. 2008, 283:27612-27619.
27. Kirkland S.C. Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells. Br. J. Cancer 2009, 101:320-326.
28. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 2007, 7:415-428.
29. Mani S.A., Yang J., Brooks M., Schwaninger G., Zhou A., Miura N., Kutok J.L., Hartwell K., Richardson A.L., Weinberg R.A. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10069-10074.
30. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.